To further evaluate whether the therapeutic efficacy of IFI35 knockdown was dependent on the induction of autophagy in vivo, the subcutaneous 786-O-shRNA tumor models were received intraperitoneal 3-MA. This evidence concerns the gene IFI35 and neoplasm.